ProNAi Therapeutics (DNAI) Posts Wider-than-Expected Q3 Loss
Tweet
Share
E-mailGet Alerts DNAI Hot Sheet
Join SI Premium – FREE
ProNAi Therapeutics (NASDAQ: DNAI) reported Q3 EPS of ($11.03), $10.55 worse than the analyst estimate of ($0.48).
For earnings history and earnings-related data on ProNAi Therapeutics (DNAI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Innovative Solutions & Support (ISSC) Tops Q3 EPS by 10c
- Pulmatrix (PULM) Reports Q2 Loss of $0.29
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
